Seizure relapse and development of drug resistance following long-term seizure remission.

Full Abstract

OBJECTIVE: To quantify and identify predictive risk factors for seizure relapse and development of drug resistance in patients who achieved long-term (>1 year) antiepileptic drug-induced seizure remission. DESIGN: Prospective cohort study. SETTING: Epilepsy Center, Rambam Medical Center. Patients Two hundred fifty-six consecutive patients who entered long-term (>1 year) antiepileptic drug-induced seizure remission were followed up prospectively for 2 years or more. MAIN OUTCOME MEASURES: Seizure relapse and development of drug-resistant epilepsy. RESULTS: Five years after entering seizure remission, 40.2% of patients experienced seizure relapse and 25.3% of patients developed drug-resistant epilepsy. The Kaplan-Meier curves could be fitted by monoexponential functions, with a maximal seizure relapse rate of 43.6%, maximal drug-resistance rate of 27.4%, and half-decay constant of 21.5 months for both curves. Treatment history served as a significant independent prognostic risk factor for both seizure relapse and development of drug resistance. The preremission seizure frequency and duration of epilepsy were also identified as significant prognostic risk factors in the univariant analysis but failed to reach statistical significance in the multivariate analysis. CONCLUSION: Seizure relapse commonly occurs in patients following long-term seizure remission. Treatment history and duration of epilepsy are predictive risk factors for both seizure relapse and development of drug resistance.

Author information

Author/s: Schiller, Yitzhak (Y);

Affiliation: Epilepsy Service, Department of Neurology, Rambam Medical Center, 1 Efron St, Haifa 31096, Israel. y_schiller(-atsign-)yahoo.com

Journal and publication information

Publication Type: Journal Article

Journal: Archives of neurology (Arch Neurol), published in United States. (Language: eng)

Reference: 2009-Oct; vol 66 (issue 10) : pp 1233-9

Dates: Created 2009/10/13; Completed 2009/10/30;

PMID: 19822778, status: MEDLINE (last retrieval date: 10/30/2009, IMS Date: )

Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.

External Links for this article
(including full text providers, if available):

Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.

This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.